Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations

Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations

Background: Small molecule receptor antagonists (gepants), or monoclonal antibodies (mAbs) against calcitonin gene-related peptide (CGRP) have recently become available for migraine prophylaxis and/or acute treatment. Considering their shared mechanisms of action, if the failure to an anti-CGRP(R) m...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Burgalassi (Author), Giulia Vigani (Author), Alberto Boccalini (Author), Francesco De Cesaris (Author), Guido Mannaioni (Author), Alberto Chiarugi (Author), Pierangelo Geppetti (Author), Luigi Francesco Iannone (Author)
Format: Book
Published: SAGE Publishing, 2024-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items